Radioactive drug trial seeks to target advanced cancers
NCT ID NCT07439120
Summary
This early-stage study is testing a new radioactive drug (68Ga/177Lu-BRP-020063) for patients with advanced cancers that have spread. First, it uses a low-radioactivity version to take pictures of the cancer. Then, a few patients may receive a slightly stronger, therapeutic dose to see if it can treat the tumors. The main goals are to check the drug's safety, how it moves through the body, and the amount of radiation it delivers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA (UC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.